Sandip Patel, MD | Addressing Patients on Cancer Care in the Time of COVID-19

Sandip Patel, MD | Addressing Patients on Cancer Care in the Time of COVID-19

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapiesПодробнее

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies

2020 Cancer Care in the Time of COVID-19 | SurgeryПодробнее

2020 Cancer Care in the Time of COVID-19 | Surgery

2020 Cancer Care in the Time of COVID-19 | Lung CancerПодробнее

2020 Cancer Care in the Time of COVID-19 | Lung Cancer

Sandip Patel, MD | Perspective on Cancer Care in the Time of COVID-19Подробнее

Sandip Patel, MD | Perspective on Cancer Care in the Time of COVID-19

Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapiesПодробнее

Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies

2020 Cancer Care in the Time of COVID-19 | Patient PerspectiveПодробнее

2020 Cancer Care in the Time of COVID-19 | Patient Perspective

Cancer Care in the Time of COVID-19Подробнее

Cancer Care in the Time of COVID-19

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of lifeПодробнее

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life

Is COVID-19 Devastating Cancer Care? | The AgendaПодробнее

Is COVID-19 Devastating Cancer Care? | The Agenda

Sandip Patel, MD - UCSD - June "Researcher of the Month"Подробнее

Sandip Patel, MD - UCSD - June 'Researcher of the Month'

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agentsПодробнее

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

CTCA PODCAST: What cancer patients needs to know about COVID-19Подробнее

CTCA PODCAST: What cancer patients needs to know about COVID-19

Lung Cancer Care in the time of Covid-19 Pandemic and TelemedicineПодробнее

Lung Cancer Care in the time of Covid-19 Pandemic and Telemedicine

Sandip Patel, MD, comments on the top stories in lung cancer from ASCO 2019Подробнее

Sandip Patel, MD, comments on the top stories in lung cancer from ASCO 2019

Dr. Sandip Patel (Pt 2): Advances and Impasses in Precision Medicine for CancerПодробнее

Dr. Sandip Patel (Pt 2): Advances and Impasses in Precision Medicine for Cancer

Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse eventsПодробнее

Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse events

#BenchToBedside S8E2: Cancer Care in the Time of COVID-19’s Delta VariantПодробнее

#BenchToBedside S8E2: Cancer Care in the Time of COVID-19’s Delta Variant